Key facts
- This page summarizes ELRAY RESOURCES, INC.'s Form 4 filing for 180 Life Sciences Corp. (ATNF).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 11 Apr 2025, 18:05.
ELRAY RESOURCES, INC. - 27 Mar 2025 Form 4 Insider Report for 180 Life Sciences Corp. (ATNF)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- ATNF
- Reported as of
- 27 Mar 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 11 Apr 2025, 18:05:04 UTC
- Prior SEC filing
- 31 Dec 2024
- Next SEC filing
- 18 Aug 2025
- Source filing
- View source filing
- Reporting owner signature
- Elray Resources, Inc., by /s/ Anthony Brian Goodman, CEO
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
ELRAY RESOURCES, INC. filed Form 4 for 180 Life Sciences Corp. (ATNF) on 11 Apr 2025.
Change
- Previous filing in this sequence was filed on 31 Dec 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ATNF
transaction
Common Stock
Conversion of derivative security
- Transaction value
- Shares
- +1,318,000
- Change %
- Price
- Shares after
- 1,318,000
- Date
- 27 Mar 2025
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ATNF
transaction
Derivative
Series B Convertible Preferred Stock
Conversion of derivative security
- Transaction value
- $0
- Shares
- -1,000,000
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 27 Mar 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,318,000
- Exercise price
- Footnotes
- F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
On March 27, 2025, Elray Resources, Inc., converted all 1,000,000 outstanding shares of Series B Convertible Preferred Stock of the Issuer which it then held into 1,318,000 shares of common stock (1.318 shares of common stock for each share of Series B Convertible Preferred Stock converted), in accordance with the terms of such preferred stock and the optional conversion right set forth therein.
Footnote F2
Each of the 1,000,000 shares of Series B Convertible Preferred Stock was convertible into 1.318 shares of common stock.
Footnote F3
The Series B Convertible Preferred Stock has no expiration date.